Kul. 4 Shock
-
Upload
friska-furnandari -
Category
Documents
-
view
215 -
download
0
Transcript of Kul. 4 Shock
![Page 1: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/1.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 1/26
Diagnosis and Management
of Shock
dr. Rudi, Sp.An
SHK 1
![Page 2: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/2.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 2/26
Objectives
• Identify the major types of shock and principles of
management
•
Review fluid resuscitation and use of vasopressor andinotropic agents
• Understand concepts of O2 supply and demand
• Discuss the differential diagnosis of oliguria
SHK 2
![Page 3: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/3.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 3/26
Shock
• Always a symptom of primary cause
• Inadequate blood flow to meet tissue oxygendemand
• May be associated with hypotension
• Associated with signs of hypoperfusion: mentalstatus change, oliguria, acidosis
SHK 3
![Page 4: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/4.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 4/26
Shock Categories
• Cardiogenic
• Hypovolemic• Distributive
• Obstructive
SHK 4
![Page 5: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/5.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 5/26
Cardiogenic Shock
• Decreased contractility
• Increased filling pressures, decreased LV
stroke work, decreased cardiac output
• Increased systemic
vascular resistance – compensatory
![Page 6: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/6.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 6/26
Hypovolemic Shock
• Decreased cardiac output
• Decreased filling pressures
• Compensatory increase in
systemic vascular resistance
SHK 6
![Page 7: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/7.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 7/26
Distributive Shock
• Normal or increased cardiac output
• Low systemic vascular resistance
• Low to normal filling pressures
• Sepsis, anaphylaxis, neurogenic,
and acute adrenal insufficiency
SHK 7
![Page 8: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/8.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 8/26
Obstructive Shock
• Decreased cardiac output
• Increased systemic vascular
resistance
•
Variable filling pressures dependenton etiology
• Cardiac tamponade, tension
pneumothorax, massive pulmonary
embolus
![Page 9: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/9.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 9/26
Cardiogenic Shock Management
• Treat arrhythmias
• Diastolic dysfunction may require
increased filling pressures
• Vasodilators if not hypotensive
• Inotrope administration
![Page 10: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/10.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 10/26
Cardiogenic Shock Management
• Vasopressor agent needed if
hypotension present to raise aortic
diastolic pressure
•
Consultation for mechanical assistdevice
• Preload and afterload reduction to
improve hypoxemia if blood pressure
adequate
![Page 11: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/11.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 11/26
Hypovolemic Shock
Management
• Volume resuscitation – crystalloid, colloid
• Initial crystalloid choices
– Lactated Ringer’s solution
– Normal saline (high chloride may produce
hyperchloremic acidosis)
• Match fluid given to fluid lost
– Blood, crystalloid, colloid
SHK 11
![Page 12: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/12.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 12/26
Distributive Shock Therapy
• Restore intravascular volume
• Hypotension despite volume therapy
– Inotropes and/or vasopressors
• Vasopressors for MAP < 60 mm Hg
• Adjunctive interventions dependent onetiology
SHK 12
![Page 13: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/13.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 13/26
Obstructive Shock Treatment
• Relieve obstruction
– Pericardiocentesis
– Tube thoracostomy
– Treat pulmonary embolus
• Temporary benefit from fluid or
inotrope administration
![Page 14: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/14.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 14/26
Fluid Therapy
• Crystalloids – Lactated Ringer’s solution
– Normal saline
• Colloids
–Hetastarch
– Albumin
– Gelatins
• Packed red blood cells
•
Infuse to physiologic endpoints
SHK 14
![Page 15: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/15.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 15/26
Fluid Therapy
• Correct hypotension first
• Decrease heart rate
•
Correct hypoperfusion abnormalities• Monitor for deterioration of oxygenation
SHK 15
![Page 16: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/16.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 16/26
Inotropic / Vasopressor Agents
• Dopamine
– Low dose (2-3 g/kg/min) – mild inotrope
plus renal effect
– Intermediate dose (4-10 g/kg/min) – inotropic effect
– High dose ( >10 g/kg/min) – vasoconstriction
–
Chronotropic effect
SHK 16
![Page 17: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/17.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 17/26
Inotropic Agents
• Dobutamine
– 5-20 g/kg/min
– Inotropic and variable chronotropic effects
– Decrease in systemic vascular resistance
SHK 17
![Page 18: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/18.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 18/26
Inotropic / Vasopressor Agents
• Norepinephrine
– 0.05 g/kg/min and titrate to effect
– Inotropic and vasopressor effects
– Potent vasopressor at high doses
SHK 18
![Page 19: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/19.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 19/26
Inotropic / Vasopressor Agents
• Epinephrine
– Both and actions for inotropic and
vasopressor effects
– 0.1 g/kg/min and titrate
– Increases myocardial O2 consumption
SHK 19
![Page 20: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/20.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 20/26
Therapeutic Goals in Shock
• Increase O2 delivery
• Optimize O2 content of blood
• Improve cardiac output and
blood pressure
• Match systemic O2 needs with O2 delivery
• Reverse/prevent organ hypoperfusion
![Page 21: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/21.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 21/26
Oliguria
• Marker of hypoperfusion• Urine output in adults
<0.5 mL/kg/hr for >2 hrs
•
Etiologies – Prerenal
– Renal
–
Postrenal
SHK 21
![Page 22: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/22.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 22/26
Evaluation of Oliguria
• History and physical examination
• Laboratory evaluation
– Urine sodium
– Urine osmolality or specific gravity
– BUN, creatinine
SHK 22
![Page 23: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/23.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 23/26
![Page 24: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/24.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 24/26
Therapy in Acute Renal Insufficiency
• Correct underlying cause
• Monitor urine output
• Assure euvolemia
• Diuretics not therapeutic
•Low-dose dopamine may urine flow
• Adjust dosages of other drugs
• Monitor electrolytes, BUN, creatinine
• Consider dialysis or hemofiltration
SHK 24
![Page 25: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/25.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 25/26
Pediatric Considerations
• BP not good indication of hypoperfusion
• Capillary refill, extremity temperature better
signs of poor systemic perfusion
• Epinephrine preferable to norepinephrine due to more
chronotropic benefit
• Fluid boluses of 20 mL/kg titrated to BP or total 60
mL/kg, before inotropes or vasopressors
SHK 25
![Page 26: Kul. 4 Shock](https://reader031.fdocuments.in/reader031/viewer/2022021323/577cc7a41a28aba711a18b5d/html5/thumbnails/26.jpg)
8/12/2019 Kul. 4 Shock
http://slidepdf.com/reader/full/kul-4-shock 26/26
Pediatric Considerations
• Neonates – consider congenital
obstructive left heart syndrome as cause of
obstructive shock
• Oliguria – <2 yrs old, urine volume <2 mL/kg/hr
– Older children, urine volume
<1 mL/kg/hr
SHK 26